 (OTC:PHYMF) Stock, Quote.Headers.trade-ideas

On Wednesday, Amazon.com&nbsp;Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>)&nbsp;<a target="_blank" href="https://www.benzinga.com/topic/amazon" rel="noreferrer noopener">announced that it</a> was withdrawing its operations in Quebec, Canada, and losing about 1,700 full-time jobs.
The move will also affect approximately 250 seasonal workers. Amazon agreed to compensate for the loss with a package including up to 14 weeks&#8217; pay and job placement resources, Reuters cites Amazon spokesperson Barbara Agrait.
The American e-commerce giant&#8217;s move followed U.S. President Donald Trump&#8217;s threat to slap <a target="_blank" href="https://www.benzinga.com/25/01/43101141/chinese-stocks-rally-after-trump-skips-tariff-threats-boosting-market-optimism" rel="noreferrer noopener">25% tariffs on</a> imports from Canada and Mexico on February 1.
Also Read: <a target="_blank" href="https://www.benzinga.com/24/11/42216863/nvidia-intel-suppliers-rethink-mexico-operations-amid-trumps-tariff-threat" rel="noreferrer noopener">Nvidia, Intel Suppliers Rethink Mexico Operations Amid Trump&#8217;s Tariff Threat</a>
Amazon has seven sites in Quebec, including sorting centers and warehouses, most of which are in the Montreal area.
Over the next two months, Amazon will phase out operations across seven sites in the province, the only location in Canada with unionized Amazon employees. To save costs, it will return to a third-party delivery model.
According to a CTV news report, Amazon <a target="_blank" href="https://www.ctvnews.ca/montreal/article/amazon-is-ceasing-operations-in-quebec/" rel="noreferrer noopener">had lost the challenge</a> against workers to unionize in the labor tribunal in October.
In 2023, Amazon Web Services (AWS) launched <a target="_blank" href="https://www.benzinga.com/news/23/12/36321525/amazons-aws-unveils-major-expansion-in-canada-a-gateway-to-unprecedented-growth-and-opportunities" rel="noreferrer noopener">its second infrastructure</a> region in Canada, the AWS Canada West (Calgary) Region.&nbsp;
The Amazon cloud unit released an economic impact study projecting a $17.9 billion investment in Canada through 2037, surrounding the new Calgary region and the existing Quebec region, supporting over 9,300 full-time equivalent jobs annually.&nbsp;
Amazon stock surged 51% in the last 12 months. Investors can gain exposure to the stock through Vanguard Consumer Discretion ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VCR#NYSE">VCR</a>) and SPDR Select Sector Fund &#8211; Consumer Discretionary (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>).
Price Action: AMZN stock traded lower by 0.32% to $234.25 premarket at the last check on Wednesday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/25/01/43139410/softbanks-role-in-500-billion-stargate-ai-venture-seen-as-major-growth-driver-analyst-says" target="_blank" rel="noreferrer noopener">SoftBank&#8217;s Role in $500 Billion Stargate AI Venture Seen as Major Growth Driver, Analyst Says</a></li>
</ul>
Image Via Shutterstock

Government

News

Regulations

Tech

Media

AMZN

Select Sector SPDR-Consumer Discretionary

Amazon To Shut 7 Quebec Fulfillment Centers, Axe Around 2,000 Jobs

JP Morgan analyst Mark Strouse maintains GE Vernova (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>) with a Overweight and raises the price target from $374 to $436.

Price Target

Analyst Ratings

JP Morgan Maintains Overweight on GE Vernova, Raises Price Target to $436

HC Wainwright &amp; Co. analyst Edward White maintains Valneva (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VALN#NASDAQ">VALN</a>) with a Buy and lowers the price target from $19 to $18.

VALN

HC Wainwright & Co. Maintains Buy on Valneva, Lowers Price Target to $18

Morgan Stanley analyst Kristine Liwag maintains Textron (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TXT#NYSE">TXT</a>) with a Equal-Weight and lowers the price target from $86 to $82.

Morgan Stanley Maintains Equal-Weight on Textron, Lowers Price Target to $82

JP Morgan analyst Samik Chatterjee maintains Amphenol (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APH#NYSE">APH</a>) with a Overweight and raises the price target from $85 to $90.

JP Morgan Maintains Overweight on Amphenol, Raises Price Target to $90

HC Wainwright &amp; Co. analyst Scott Buck initiates coverage on Worksport (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WKSP#NASDAQ">WKSP</a>) with a Buy rating and announces Price Target of $1.5.

Initiation

WKSP

HC Wainwright & Co. Initiates Coverage On Worksport with Buy Rating, Announces Price Target of $1.5

Based on an ongoing assessment of the impact from Hurricanes Helene and Milton, current business conditions, retail trends and other factors, the Company continues to expect fiscal year 2025 Adjusted EPS of $1.80 to $2.80 per diluted share, and fiscal year 2025 Adjusted EBITDA in the range of $150 million to $180 million.&nbsp;
"While economic conditions in the recreational marine industry remain challenging, we anticipate that the pace of activity improves as we move into the spring selling season," the company said.

Management

MarineMax Reaffirms FY25 Guidance For Adjusted EPS Of $1.80 - $2.80, Est $2.37

Morgan Stanley analyst Cameron Mansson-Perrone maintains Sirius XM Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIRI#NASDAQ">SIRI</a>) with a Underweight and lowers the price target from $23 to $21.

SIRI

Morgan Stanley Maintains Underweight on Sirius XM Holdings, Lowers Price Target to $21

Together, the companies intend to develop new software capabilities within BD flow cytometer instrument software to be compatible with Biosero's Green Button Go software, as well as jointly support biopharmaceutical and contract research organizations with their custom research needs, to enable easy integration with robotic arms.

Large Cap

Health Care

Contracts

General

BD (Becton, Dickinson And Company) And Biosero Announced A Framework Collaboration Agreement To Enable And Facilitate Robotic Arm Integration With BD Flow Cytometry Instruments To Accelerate Drug Discovery And Development

Jefferies analyst John Hecht maintains Ally Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALLY#NYSE">ALLY</a>) with a Hold and raises the price target from $35 to $40.

ALLY

Jefferies Maintains Hold on Ally Financial, Raises Price Target to $40

MarineMax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HZO#NYSE">HZO</a>) reported quarterly earnings of $0.17 per share which beat the analyst consensus estimate of $(0.19) by 189.47 percent. This is a 10.53 percent decrease over earnings of $0.19 per share from the same period last year. The company reported quarterly sales of $468.46 million which missed the analyst consensus estimate of $485.14 million by 3.44 percent. This is a 11.15 percent decrease over sales of $527.27 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

MarineMax Q1 2025 Adj EPS $0.17 Beats $(0.19) Estimate, Sales $468.46M Miss $485.14M Estimate

Keefe, Bruyette &amp; Woods analyst Damon Delmonte maintains Nicolet Bankshares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIC#NYSE">NIC</a>) with a Market Perform and raises the price target from $110 to $115.

Keefe, Bruyette & Woods Maintains Market Perform on Nicolet Bankshares, Raises Price Target to $115

AZZ Announced That Effective March 1, 2025, Jeff Vellines Will Serve As President And COO Of The Precoat Metals Business Segment. Kurt Russell, AZZ's Former President And COO Of The Precoat Metals Business Segment Will Transition Into Senior Vice President And Chief Strategic Officer

Needham analyst Kyle Peterson reiterates Affirm Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>) from Hold to Hold.

Reiteration

AFRM

Needham Reiterates Hold on Affirm Holdingsto Hold

PLRZ

Polyrizon Has Commenced Preliminary Work Related To The Good Manufacturing Practice Manufacturing Process For Its PL-14 Allergy Blocker In Preparation For Its Planned 2025 Clinical Trial

Canaccord Genuity analyst Richard Close maintains Evolent Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVH#NYSE">EVH</a>) with a Buy and lowers the price target from $23 to $16.

Canaccord Genuity Maintains Buy on Evolent Health, Lowers Price Target to $16

WIIM

Alaska Air Group shares are trading higher after the company reported better-than-expected Q4 EPS and revenue and issued FY25 guidance above estimates.

GOLF

Acushnet Holdings shares are trading lower after JP Morgan downgraded the stock from Neutral to Underweight.

Benchmark analyst David Williams reiterates Plexus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLXS#NASDAQ">PLXS</a>) with a Buy and maintains $165 price target.

Comments

(PHYMF) Forecast

(OTC:PHYMF) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga